1980
DOI: 10.1079/pns19800036
|View full text |Cite
|
Sign up to set email alerts
|

Animal models for the study of energy balance

Abstract: Dairying, University of Reading, Shinfield, Reading RG2 @T The most obvious outcome of the failure to regulate energy balance effectively in animals and man is obesity. To learn how obesity arises and may be prevented, we must understand how animals regulate energy balance or metabolism, but a concentration on obesity as such may focus too much research attention on the adipose tissue, a proliferation of which is the outward sign of a tendency towards positive energy balance though not necessarily the cause of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0
1

Year Published

1985
1985
2014
2014

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 24 publications
0
2
0
1
Order By: Relevance
“…Therefore, the daily net energy balance (intake-loss) in vehicle-and ipragliflozin-treated rats was 91.0 and 77.9 kcal/day, respectively, with the net energy balance in ipragliflozin-treated rats coming out to 85.6% that of vehicle-treated rats. Assuming 6.16 kcal/g body fat for rodents (Gurr, 1980), this deficit of 13.1 kcal/day in the ipragliflozin-treated group could explain the fat weight loss of 2.13 g/day and a 63.9 g total body weight loss after 30-day treatment. Interestingly, this degree of weight loss is consistent with the differences in actual body weight between the vehicle and ipragliflozin groups (61.8 g) (Figure 1A), strongly suggesting that ipragliflozin reduced fat weight by promoting negative energy balance in HFD rats.…”
Section: Discussionmentioning
confidence: 99%
“…Therefore, the daily net energy balance (intake-loss) in vehicle-and ipragliflozin-treated rats was 91.0 and 77.9 kcal/day, respectively, with the net energy balance in ipragliflozin-treated rats coming out to 85.6% that of vehicle-treated rats. Assuming 6.16 kcal/g body fat for rodents (Gurr, 1980), this deficit of 13.1 kcal/day in the ipragliflozin-treated group could explain the fat weight loss of 2.13 g/day and a 63.9 g total body weight loss after 30-day treatment. Interestingly, this degree of weight loss is consistent with the differences in actual body weight between the vehicle and ipragliflozin groups (61.8 g) (Figure 1A), strongly suggesting that ipragliflozin reduced fat weight by promoting negative energy balance in HFD rats.…”
Section: Discussionmentioning
confidence: 99%
“…Dapagliflozin is a potent and selective SGLT2 inhibitor (16) which has been shown to induce glucose excretion by 20–85 g/day in humans (17,18,19) and 0.5–1.9 g/day in 200 g rats (20), which would be roughly equivalent to a caloric deficit of 80–340 kcal/day in humans and 2–7.6 kcal/day in a 200 g rodent. Assuming 6.16 kcal/g body fat for rodents (21) and 3,500 kcal/lb body fat for humans, these caloric deficits would predict weight loss of 0.32–1.2 g/day in a rat and 0.022–0.097 lb/day in a human. Zhang (22) reported an average weight loss of 2.5 kg in early‐stage diabetic patients where average urinary glucose excretion was 71.2 g/24 h, which is 20% less than the 3.05 kg which would have been predicted from the glucose excretion values.…”
Section: Introductionmentioning
confidence: 99%
“…Zu beachten ist, daR zum Vergleich der absoluten Warmeproduktion nur Versuche mit konstanten Mengen an zugefuhrter Bruttoenergie bei den einzelnen Versuchsgruppen herangezogen werden diirfen. Bei unterschiedlicher Energiezufuhr ist namlich mit bedeutend starkerer Beeinflussung der Warmebildung zu rechnen (GURR 1980;KIRCHGESSNER et al 1983a).…”
unclassified